Download presentation
Presentation is loading. Please wait.
Published byGarry Mills Modified over 9 years ago
1
(FGreen RCCSP 03/10/06) London Cancer New Drugs Group Fionnuala Green Regional Co-ordinator Cancer Services Pharmacist (job share)
2
(FGreen RCCSP 03/10/06) Background Established in 2002 Sub committee of London Cancer Networks Steering group 3 members from each of the 5 London networks Observers: Scotland, N. Ireland, U.K. networks
3
(FGreen RCCSP 03/10/06) Aim “ to facilitate consistency of approach in London by informing the managed entry of new drugs in cancer treatments and to promote the cost- effective and equitable provision of all medicines used in cancer management “
4
(FGreen RCCSP 03/10/06) Objectives Make recommendations on treatment taking into account clinical effectiveness, cost and likely service impact. Affordability considered at local level
5
(FGreen RCCSP 03/10/06) Criteria for inclusion on work plan Rare/specialist treatments Large potential population High cost Equity and access issues Politically sensitive Rare conditions
6
(FGreen RCCSP 03/10/06) Criteria for inclusion on work plan NICE Clarification Pre-NICE Non- NICE indications Local knowledge
7
(FGreen RCCSP 03/10/06)
8
Outputs Draft briefings for consultation Final briefings Recommendations
9
(FGreen RCCSP 03/10/06) Benefits to NICaN Oncology/Haematology D & T Committee Access to draft briefing papers with caveat only to be shared within the NHS Recommendations available well in advance of NICE Recommendations for non NICE medicines
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.